Founded by Roger Avery in the late 1960s, Avery Biomedical Devices makes implanted diaphragm pacemaker systems that stimulate the phrenic nerves to support breathing. The company’s predecessor introduced the first commercially distributed diaphragm pacemaker in 1971, and Avery has since manufactured more than 10,000 neurostimulators implanted in over 50 countries. Renamed in 2005, the Long Island manufacturer’s Spirit system has full FDA approval for adult and pediatric use and is produced under an ISO 13485 quality system.
ISO 13485:2016 Quality Management System
certification
FDA Premarket Approval P860026
certification
CE Marking under the European Active Implantable Medical Device Directive
certification
United States FDA Device Registration and Inspection
registration
Argentina ANMAT Registration
registration
Colombia INVIMA Registration
registration
Israel Ministry of Health Medical Device Registration
registration
Russian Ministry of Health Registration
registration
United Kingdom MHRA Registration
registration